Brief: Ligand Spins Out And Merges Pelican Subsidiary With Primordial Genetics To Form Primrose Bio

Ligand Pharmaceuticals Incorporated

18/09/2023 22:23

Ligand Pharmaceuticals Inc  LGND.O :
    * LIGAND SPINS OUT AND MERGES PELICAN SUBSIDIARY WITH
PRIMORDIAL
GENETICS TO FORM PRIMROSE BIO
    * LIGAND PHARMACEUTICALS INC - LIGAND IMPROVES CASH EXPENSE
OUTLOOK AND RAISES EPS GUIDANCE
    * LIGAND PHARMACEUTICALS INC- LIGAND IMPROVES CASH EXPENSE
OUTLOOK
AND RAISES EPS GUIDANCE
    * LIGAND PHARMACEUTICALS INC- RETAINS ALL PELICAN COMMERCIAL
ROYALTIES AND WILL OWN 49.9% OF PRIMROSE BIO, INC. AS A
STAND-ALONE PRIVATE COMPANY
    * LIGAND PHARMACEUTICALS INC SEES FY ADJUSTED DILUTED EPS OF
$5.10
TO $5.25

Source text for Eikon:  ID:nBwbRCZYBa 
Further company coverage:  LGND.O